title: Solid tumor treatment workshop summary.
abstract: Retinoic acids exert a wide range of biological activities following binding to the cognate nuclear receptors, which has several members (RAR-alpha, beta, gamma and RXR-alpha, beta, gamma). Retinoic acids lead to several different effects on tumor cells and include cell differentiation, inhibition of cell proliferation and apoptosis. The expression and abundance of each receptor type, and the distinct role of each receptor type related to biologic effect is under investigation. Similarly the mechanism(s) responsible for favorable responses in certain tumor types (skin, cervical) needs to be understood to best utilize this family of compounds, either alone or in various combinations. The significancer of drug-drug interaction in regard to their effects on pharmacokinetics, receptor modulation and regulation of cytoplasmic retinoic acid receptor binding proteins (CRABPs) should be carefully evaluated in pre-clinical and clinical trials. Furthermore, appropriate models to study combinations of RAs with other biological response modifiers are needed.
authors: University of Southern California, School of Medicine, Department of Internal Medicine, Los Angeles.
authors: P S
authors: PS
authors: Gill
authors: D
authors: D
authors: Parkinson
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012176:Retinoids / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D012176:Retinoids